Text Modules


Share

Program Content

Activities

  • AEs With TROP2 ADCs
    Identification and Management of AEs With TROP-2–Targeted ADCs
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 04, 2024

    Expires: April 03, 2025

  • AEs With TROP2 ADCs
    Identification and Management of Adverse Events With TROP-2–Targeted ADCs
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 04, 2024

    Expires: April 03, 2025

  • TROP-2 in NSCLC
    TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 25, 2024

    Expires: April 24, 2025

  • TROP-2 in NSCLC
    TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 25, 2024

    Expires: April 24, 2025

  • TROP2 Targeted Tx in Adv NSCLC
    Clinical Landscape of TROP-2–Targeted Therapy in Advanced/Metastatic NSCLC
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 24, 2024

    Expires: June 23, 2025

  • TROP2 Targeted Tx in Adv NSCLC
    Clinical Landscape of TROP-2–Targeted Therapy in Advanced/Metastatic NSCLC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2024

    Expires: June 20, 2025

  • TROP 2 Combination Therapy
    Novel Combinatorial Approaches With TROP-2–Targeted Therapy in Advanced NSCLC
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 10, 2024

    Expires: July 09, 2025

  • TROP 2 Combination Therapy
    Novel Combinatorial Approaches With TROP-2–Targeted Therapy in Advanced NSCLC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 10, 2024

    Expires: July 09, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.